Market Tracker

05/24 3:35pm ET

Bio-Techne Corp (NASDAQ:TECH)

106.74
BATS BZX Real-Time Price
As of 3:33pm ET
 +1.64 / +1.56%
Today’s Change
79.95
Today|||52-Week Range
114.56
+18.60%
Year-to-Date
TrovaGene (TROV) Q1 Loss Wider than Expected, Stock Gains
May 11 / Zacks.com - Paid Partner Content
Bio-Techne (TECH): Moving Average Crossover Alert
May 10 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close105.10
Today’s open106.04
Day’s range105.56 - 106.74
Volume7,146
Average volume (3 months)240,167
Market cap$3.9B
Dividend yield1.20%
Data as of 3:33pm ET, 05/24/2016

Growth & Valuation

Earnings growth (last year)-3.67%
Earnings growth (this year)+6.62%
Earnings growth (next 5 years)+12.50%
Revenue growth (last year)+26.41%
P/E ratio37.8
Price/Sales8.11
Price/Book4.61

Competitors

 Today’s
change
Today’s
% change
ALRAlere Inc+0.29+0.71%
NEOGNeogen Corp+1.54+3.21%
AAAPAdvanced Accelerator...+0.39+1.36%
GHDXGenomic Health Inc+1.23+4.83%
Data as of 3:20pm ET, 05/24/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)$0.95
Annual revenue (last year)$452.2M
Annual profit (last year)$107.7M
Net profit margin23.82%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Charles R. Kummeth
CFO, VP-Finance &
Chief Accounting Officer
James T. Hippel
Corporate headquarters
Minneapolis, Minnesota

Forecasts